Wedbush Reiterates an 'Underperform' on Discovery Laboratories (DSCO); Financing Overhang Remains;
DSCO Hot Sheet
Rating Summary:2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Wedbush reiterates an Underperform rating on Discovery Laboratories (Nasdaq: DSCO)
Wedbush analyst says, "Management intends to explore strategic alternatives including potential additional financings as well as business alliances and commercial and development partnerships. Advancement of Surfaxin LS and Aerosurf depends upon the securitization of strategic alliances and necessary capital...Capital restraints remain an issue. The company ended Q3:09 with $17.7 million in cash, which is enough to sustain operations until Q1:10, per our estimates. Our estimates exclude capital available through two existing CEFFs as the floor prices are $0.60 and $1.15, respectively...Execution and financial risks remain our forefront concern. In addition, we view the remaining pipeline as one with inherent significant development risks."
To see more analyst ratings on DSCO Click Here.
Wedbush analyst says, "Management intends to explore strategic alternatives including potential additional financings as well as business alliances and commercial and development partnerships. Advancement of Surfaxin LS and Aerosurf depends upon the securitization of strategic alliances and necessary capital...Capital restraints remain an issue. The company ended Q3:09 with $17.7 million in cash, which is enough to sustain operations until Q1:10, per our estimates. Our estimates exclude capital available through two existing CEFFs as the floor prices are $0.60 and $1.15, respectively...Execution and financial risks remain our forefront concern. In addition, we view the remaining pipeline as one with inherent significant development risks."
To see more analyst ratings on DSCO Click Here.
You May Also Be Interested In
- UBS Maintains a 'Neutral' on VeriFone (PAY); Europe Demand Healthy, but FX Emerges as Headwind
- Barclays Maintains an 'Equalweight' on Costco Wholesale (COST); Slight Bump To FY12 Estimates After Good Qtr
- Barclays Lowers Estimates on Tiffany & Co. (TIF); Still Sees Significant Value
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
